Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 2/2021

01-03-2021 | Atrial Fibrillation | Case Reports

Device related thrombosis after left atrial appendage occlusion: does thrombus location always predicts its origin?

Authors: E. Flores-Umanzor, P. Cepas-Guillen, L. Sanchis, A. Regueiro, R. Navarro, S. Brugaletta, B. Vidal, M. Sitges, M. Sabaté, Xavier Freixa

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 2/2021

Login to get access

Excerpt

This is the case of a 65-year-old male with permanent atrial fibrillation (AF), CHA2DS2VASc of 7, and previous history of intracranial hemorrhage (ICH) under oral anticoagulation. The patient underwent left atrial appendage occlusion (LAAO) with the implant of a 25-mm Amulet device without complications. Device implantation was slightly deep, and pulmonary ridge was not covered by the device disc (Fig. 1a). The patient was discharged under dual antiplatelet treatment (DAPT). At 3 months, TEE showed a small thrombus below the pulmonary ridge (Fig. 1b). Considering the small size of the thrombus and previous history of ICH, DAPT was continued. A new TEE after 2 months showed a giant central protruding thrombus (25 × 23 mm) (Fig. 1c). DAPT was therefore substituted by apixaban 2.5 mg/12 h (adjusted for renal function). After 3 months, the size of the thrombus was clearly smaller (11 × 10 mm) (Fig. 1d), and apixaban was continued. Six months later, TEE showed complete DRT resolution (Fig. 1e). Aspirin was therefore started, and an additional TEEs showed no novel thrombus (Fig. 1f). The patient did not experience any symptom that could suggest an embolic event during the clinical follow-up.
Literature
2.
go back to reference Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet Observational Study. JACC Cardiovasc Interv. 2019;12(11):1003–14.CrossRef Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet Observational Study. JACC Cardiovasc Interv. 2019;12(11):1003–14.CrossRef
3.
go back to reference Korsholm K, Jensen JM, Norgaard BL, et al. Detection of device related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography. Circ Cardiovasc Interv. 2019;12(9):e008112.CrossRef Korsholm K, Jensen JM, Norgaard BL, et al. Detection of device related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography. Circ Cardiovasc Interv. 2019;12(9):e008112.CrossRef
6.
go back to reference Fauchier L, Cinaud A, Brigadeau F, et al. Device related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–36.CrossRef Fauchier L, Cinaud A, Brigadeau F, et al. Device related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–36.CrossRef
7.
go back to reference Mill J, Olivares A, Arzamendi D, et al. Impact of flow dynamics on device related thrombosis after left atrial appendage occlusion. Can J Cardiol. 2020. In press;36:968.e13–4.CrossRef Mill J, Olivares A, Arzamendi D, et al. Impact of flow dynamics on device related thrombosis after left atrial appendage occlusion. Can J Cardiol. 2020. In press;36:968.e13–4.CrossRef
8.
go back to reference Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12.CrossRef Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12.CrossRef
Metadata
Title
Device related thrombosis after left atrial appendage occlusion: does thrombus location always predicts its origin?
Authors
E. Flores-Umanzor
P. Cepas-Guillen
L. Sanchis
A. Regueiro
R. Navarro
S. Brugaletta
B. Vidal
M. Sitges
M. Sabaté
Xavier Freixa
Publication date
01-03-2021
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/2021
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-020-00819-6

Other articles of this Issue 2/2021

Journal of Interventional Cardiac Electrophysiology 2/2021 Go to the issue